R&D, Pharmacovigilance & Regulatory Affairs
R&D, Pharmacovilance & Regulatory Affairs
Researching, developing, testing and launching new drug solutions. The development process lasts from 8 to 10 years and is made up of 4 phases.
| Title | Location |
Date
|
Req ID | |
|---|---|---|---|---|
|
Senior Director, Clinical Excellence AIR - Bronchiectasis & Non-obstructive Lung Diseases
Europe, IT
Oct 23, 2025
6111
|
||||
|
Ad Promo Manager, Americas Regulatory Affairs, Global Rare Diseases
Boston, MA, US
Oct 26, 2025
6005
|